Ledger.Open graph →

SEC Form D · filed October 21, 2020

InCarda Therapeutics, Inc

Offering

$50.0M

Sold

$28.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

NEWARK, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Alan Colowick · NEWARK, CADirector Johan Christenson · NEWARK, CADirector Dan Welch · NEWARK, CADirector Andrew Elbardissi · NEWARK, CADirector Grace Colon · NEWARK, CAExec · Director Isaac Cheng · Charlestown, MADirector Arun Kurichety · Irvine, CADirector Mark Simo · Carlsbad, CADirector Boris Said · Carlsbad, CAExec · Director Jonathan Ghitis · Aventura, FLDirector Brian Simo · Carlsbad, CADirector Earl Jones · Cambridge, MAExec · Director Richard Brenner · ORLANDO, FLDirector Michael Otworth · ORLANDO, FLDirector James Donnally · ORLANDO, FLDirector Greg Wasson · ORLANDO, FLDirector Isaac Cheng · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗